Evan Lippman
Corporate Officer/Principal bij ALNYLAM PHARMACEUTICALS, INC.
Profiel
Evan Lippman is currently the Chief Corporate Development & Strategy Officer at Alnylam Pharmaceuticals, Inc. Prior to his current position, he held the role of Senior VP, Chief Financial & Business Officer at Aileron Therapeutics, Inc. from 2015 to 2016.
He also served as the Senior Vice President-Neurodegenerative Diseases at EMD Serono, Inc. and as the President & Chief Operating Officer at Intima Bioscience, Inc. Mr. Lippman completed his undergraduate studies at Bucknell University and Georgia State University.
He holds an MBA from Cornell University.
Actieve functies van Evan Lippman
| Bedrijven | Functie | Begin |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 21-09-2022 |
Eerdere bekende functies van Evan Lippman
| Bedrijven | Functie | Einde |
|---|---|---|
| AILERON THERAPEUTICS, INC. | Director of Finance/CFO | 31-12-2016 |
Intima Bioscience, Inc.
 Intima Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Intima Bioscience, Inc. is a bioscience company that is advancing checkpoint cell therapy for solid tumors with curative intent. The private company is based in New York, NY. The company combines the use of patients' own immune cells with immune checkpoint targeting. Intima is currently running a phase 1/2 clinical study of its checkpoint cell therapy, which targets the immune checkpoint cish in patients with gastrointestinal and colon cancers. Alessandro Riva has been the CEO of the company since 2021. | President | - |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Corporate Officer/Principal | - |
Opleiding van Evan Lippman
| Bucknell University | Undergraduate Degree |
| Georgia State University | Undergraduate Degree |
| Cornell University | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| AILERON THERAPEUTICS, INC. | Health Technology |
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
Intima Bioscience, Inc.
Intima Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Intima Bioscience, Inc. is a bioscience company that is advancing checkpoint cell therapy for solid tumors with curative intent. The private company is based in New York, NY. The company combines the use of patients' own immune cells with immune checkpoint targeting. Intima is currently running a phase 1/2 clinical study of its checkpoint cell therapy, which targets the immune checkpoint cish in patients with gastrointestinal and colon cancers. Alessandro Riva has been the CEO of the company since 2021. | Health Technology |
